Chairs: Nieng Yan & Gregory Challis
Development of granulin derived peptides as wound healing agents (#17)
8:30 AM
Validating the relaxin-3 neuropeptide receptor, RXFP3, as a promising target for the treatment of obesity and depression (#18)
9:00 AM
A synthetic glycolipid peptide vaccine for malaria (#19)
9:25 AM
Rapid screening of cyclotide-based libraries for the selection of potent E3 ligase antagonists (#20)
9:45 AM
Highly specific biochips for early diagnosis in search of Eldorado (#21)
10:05 AM